Speech, Linguistic and Acoustic Markers in Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

58

Participants

Timeline

Start Date

January 13, 2020

Primary Completion Date

September 1, 2023

Study Completion Date

February 28, 2025

Conditions
Parkinson DiseaseCognitive Impairment, MildSpeech
Interventions
DIAGNOSTIC_TEST

Cognitive Battery

Participants will be asked to complete a series of cognitive testing (testing of concentration, memory, and other thinking abilities).

BEHAVIORAL

Voice, Speech and Language Analysis

Participants will be asked to perform speaking and reading tasks, which will be recorded. Participants will be asked to complete a laptop-based test of language comprehension.

BEHAVIORAL

Questionnaires and Clinical Assessments

Participants with Parkinson's disease will complete an examination of their symptoms and questionnaires assessing disease symptoms, mood and activities of daily living. Healthy controls participants will be asked to complete questionnaires on mood.

GENETIC

DNA Analysis

Participants will have their blood drawn for DNA analysis.

Trial Locations (1)

01655

UMass Medical School/UMass Memorial Medical Center, Worcester

All Listed Sponsors
collaborator

Boston University

OTHER

collaborator

VA Puget Sound Health Care System

FED

collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

collaborator

Massachusetts Institute of Technology/Lincoln Labs

UNKNOWN

lead

University of Massachusetts, Worcester

OTHER

NCT04273672 - Speech, Linguistic and Acoustic Markers in Parkinson's Disease | Biotech Hunter | Biotech Hunter